Search tips
Search criteria 


Logo of jpnSubmit a ManuscriptEmail AlertsAbout JPNJournal of Psychiatry and Neuroscience
J Psychiatry Neurosci. 1991 December; 16(5): 262–266.
PMCID: PMC1188363

Effect of bromocriptine in patients with apomorphine-responsive erectile impotence: an open study.


An open pilot study was undertaken to investigate the therapeutic effect of the dopaminergic agent, bromocriptine (BC), in impotent patients who developed an erectile response to the dopamine receptor agonist, apomorphine. Eight out of 17 patients reported improvement in ability to obtain an erection; five of these 8 subjects were able to achieve penetration. The optimum dose of BC was 2.5 - 11.25 mg/day. A double-blind placebo-controlled study is merited.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (626K), or click on a page image below to browse page by page.

Articles from Journal of Psychiatry & Neuroscience : JPN are provided here courtesy of Canadian Medical Association